Pelage is a regenerative medicine biotech developing innovative treatments for hair loss by activating hair follicle stem cells.
Location: United States
Total raised: $150.8M
Investors 2
| Date | Name | Website |
| 10.03.2024 | Visionary ... | visionaryv... |
| 20.11.2025 | Hawktail M... | hawktail.c... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 15.10.2025 | Series B | $120M | ARCH Ventu... |
| 18.08.2024 | Series A | $14M | - |
| 01.04.2024 | Series A | $16.8M | - |
Mentions in press and media 12
| Date | Title | Description |
| 10.11.2025 | Local Firms Advance Hair Loss Treatment Financing for Pelage GoodRx’s new platform | - |
| 15.10.2025 | Pelage Pharma raises $120M series B to untangle roots of hair loss with regenerative med | The latest strand in Pelage Pharmaceuticals’ growing funds comes from a $120 million series B fundraising round that the biotech plans to apply to its regenerative hair loss treatment. Arch Venture Partners and Google Ventures co-led the fu... |
| 15.10.2025 | Pelage Pharmaceuticals Raises $120M in Series B Financing | Pelage Pharmaceuticals, a Los Angeles, CA-based clinical-stage regenerative medicine biotechnology company, closed a $120m Series B financing. The round was co-led by ARCH Venture Partners and GV (Google Ventures), with participation from e... |
| 22.08.2024 | The Painful Truth: Rethinking Gynecological Care in America | In the realm of healthcare, gynecology often stands as a unique battleground. Women face a double-edged sword: the need for essential procedures and the fear of pain. Recent discussions have spotlighted this issue, particularly around the i... |
| 18.08.2024 | Pelage Pharmaceuticals: $14 Million (Series A-1) Raised In Round Led By GV To Address Hair Loss Treatments | Pelage Pharmaceuticals, a clinical-stage regenerative medicine company crearting a new generation of treatments for hair loss, announced that the first patients have been dosed in its Phase 2a clinical trial evaluating the safety and effica... |
| 13.08.2024 | Pelage Pharmaceutical Raises $14M Series A-1 Funding | Pelage Pharmaceutical, a Los Angeles, CA-based clinical-stage regenerative medicine company focused on hair loss, raised $14M in Series A-1 funding. The round was led by GV. The company intends to use the funds to accelerate its Phase 2 cli... |
| 01.04.2024 | Pelage Closes $16.8M Series A Round | - |
| 27.02.2024 | Pelage Pharmaceuticals Raises $16.75M in Series A Funding | Pelage Pharmaceuticals, a Los Angeles, Ca-based clinical-stage regenerative medicine company, raised $16.75M in Series A funding. The round was led by GV with participation from Main Street Advisors, Visionary Ventures and YK BioVentures. T... |
| - | 🤩 Upfront 2024: The stars were out at venture's glitziest event of the year 🤝 Venture Deals 🤝 Venture Deals 🤝 Venture Deals 📅 LA Tech Calendar 📙 What We’re Reading | 🔦 Spotlight Every year, stars from Silicon Valley and Hollywood descend on LA-based Upfront Ventures’ annual Upfront Summit. This year was no exception. For the last two days, Upfront hosted over 1,000 attendees and dozens of speakers at th... |
| - | Pelage Pharma | “Pelage Pharma” |
Show more